Literature DB >> 33236431

COVID-19 and allergy: How to take care of allergic patients during a pandemic?

Antonella Cianferoni1,2, Martina Votto3.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, is a new strain of coronavirus that has not been previously identified in humans. SARS-CoV-2 is recognized as a highly contagious respiratory virus with severe morbidity and mortality, especially in vulnerable populations. Being a novel disease, everyone is susceptible, there are no vaccine and no treatment. To contain the spread of the disease, health authorities throughout the world have restricted the social interactions of individuals in various degrees. Allergists, like other physicians, are faced with the challenge of providing care for their patients, while protecting themselves and patients from getting infected, with strategies that are in continuous evolution as states work through the different stages of social distance. Allergist provides care for patients with the most common non-communicable disease in the world: asthma, allergic rhinitis, food allergy, venom allergy, drug allergy atopic dermatitis, and urticarial syndromes. Some of these diseases are not only considered risk factors for severe reactions but also have symptoms such as cough and sneezing that are in differential diagnosis with COVID-19. As we move forward, allergy symptoms may prevent patients from working, go to school, or access medical services that increasingly are allowing only asymptomatic individuals. In this review, we will outline how to take care safety of different allergic patients during the pandemic.
© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asthma; atopic dermatitis; atopy; food allergy; immunotherapy

Mesh:

Year:  2020        PMID: 33236431     DOI: 10.1111/pai.13367

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection.

Authors:  Lindsay A Thompson; Matthew J Gurka; Stephanie L Filipp; Desmond A Schatz; Rebeccah E Mercado; David A Ostrov; Mark A Atkinson; Sonja A Rasmussen
Journal:  EClinicalMedicine       Date:  2021-06-04

2.  Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.

Authors:  Mey-Fann Lee; Chu-Hui Chiang; Shyh-Jye Lin; Chi-Sheng Wu; Yi-Hsing Chen
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

3.  Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.

Authors:  Pablo Rodriguez Del Rio; Davide Caimmi; Pilar Rico; Carmen Vidal; Moreno Carmen; Ileana M Pintoiu; Jose M Beitia Mazuecos; David Gonzalez de Olano; Pedro Cuesta Alvaro; Pascal Demoly; Moises A Calderon
Journal:  Clin Exp Allergy       Date:  2021-11-15       Impact factor: 5.401

4.  Comments on metabolomics in asthma and atopic dermatitis, and patient care during the COVID-19 pandemic.

Authors:  Philippe Eigenmann
Journal:  Pediatr Allergy Immunol       Date:  2021-11       Impact factor: 6.377

Review 5.  Allergy and Immunotherapy During the Pandemic.

Authors:  Elizabeth Mahoney Davis
Journal:  Curr Otorhinolaryngol Rep       Date:  2022-03-09

6.  Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case series.

Authors:  Martina Votto; Viola Santi; Marta Bajeli; Maria De Filippo; Elisa Deidda; Emanuela De Stefano; Francesco Dianin; Chiara Raviola; Cecilia Silvi; Gian Luigi Marseglia; Amelia Licari
Journal:  Acta Biomed       Date:  2022-06-06

Review 7.  Obesity and COVID-19 in children and adolescents: a double pandemic.

Authors:  Ilaria Brambilla; Francesco Delle Cave; Carmen Guarracino; Maria De Filippo; Martina Votto; Amelia Licari; Carmelo Pistone; Enrico Tondina
Journal:  Acta Biomed       Date:  2022-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.